North America Congestive Heart Failure Treatment Devices Market Size & Outlook
North America congestive heart failure treatment devices market, 2018-2030 (US$M)
Related Markets
North America congestive heart failure treatment devices market highlights
- The North America congestive heart failure treatment devices market generated a revenue of USD 11,242.9 million in 2023.
- The market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
- In terms of segment, ventricular assist devices was the largest revenue generating product in 2023.
- Ventricular assist devices is the most lucrative product segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 11,242.9 million |
| Market revenue in 2030 | USD 17,870.1 million |
| Growth rate | 6.8% (CAGR from 2023 to 2030) |
| Largest segment | Ventricular assist devices |
| Fastest growing segment | Ventricular assist devices |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ventricular assist devices |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, BIOTRONIK, Abbott Laboratories |
Other key industry trends
- In terms of revenue, North America region accounted for 40.3% of the global congestive heart failure treatment devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 2,350.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Congestive Heart Failure Treatment Devices Market Scope
Congestive Heart Failure Treatment Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America congestive heart failure treatment devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Ventricular assist devices was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America congestive heart failure treatment devices market based on ventricular assist devices covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest revenue share in 2015 owing to the high prevalence of cardiac disorders. According to the American Heart Association, 17.3 million deaths occur due to cardiovascular disorders and this number is expected to rise to 23.6 million by 2030. This high prevalence led to the growth of the CHF treatment devices market in this region.
In addition, developed healthcare infrastructure in the U.S. facilitated access to advanced therapeutics. This contributed to the growth of this region. Moreover, the availability of reimbursement for cardiovascular therapies supported the growth of the North American CHF treatment devices market.
Reasons to subscribe to North America congestive heart failure treatment devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America congestive heart failure treatment devices market databook
-
Our clientele includes a mix of congestive heart failure treatment devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America congestive heart failure treatment devices market, including forecasts for subscribers. This continent databook contains high-level insights into North America congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America congestive heart failure treatment devices market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
